Dynatronics (DYNT) Competitors $0.13 0.00 (0.00%) (As of 12/20/2024 04:04 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends DYNT vs. HSCS, QNRX, BJDX, BBLG, VERO, NAOV, NDRA, HSDT, AFIB, and AVGRShould you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include Heart Test Laboratories (HSCS), Quoin Pharmaceuticals (QNRX), Bluejay Diagnostics (BJDX), Bone Biologics (BBLG), Venus Concept (VERO), NanoVibronix (NAOV), ENDRA Life Sciences (NDRA), Helius Medical Technologies (HSDT), Acutus Medical (AFIB), and Avinger (AVGR). These companies are all part of the "medical equipment" industry. Dynatronics vs. Heart Test Laboratories Quoin Pharmaceuticals Bluejay Diagnostics Bone Biologics Venus Concept NanoVibronix ENDRA Life Sciences Helius Medical Technologies Acutus Medical Avinger Heart Test Laboratories (NASDAQ:HSCS) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking, profitability, risk and earnings. Is HSCS or DYNT more profitable? Heart Test Laboratories has a net margin of 0.00% compared to Dynatronics' net margin of -8.88%. Dynatronics' return on equity of -41.41% beat Heart Test Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A -144.12% -94.48% Dynatronics -8.88%-41.41%-10.12% Which has more volatility & risk, HSCS or DYNT? Heart Test Laboratories has a beta of 3.23, indicating that its stock price is 223% more volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Do analysts rate HSCS or DYNT? Heart Test Laboratories presently has a consensus price target of $13.50, suggesting a potential upside of 252.48%. Given Heart Test Laboratories' stronger consensus rating and higher probable upside, research analysts clearly believe Heart Test Laboratories is more favorable than Dynatronics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in HSCS or DYNT? Dynatronics received 304 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 83.33% of users gave Heart Test Laboratories an outperform vote while only 48.58% of users gave Dynatronics an outperform vote. CompanyUnderperformOutperformHeart Test LaboratoriesOutperform Votes583.33% Underperform Votes116.67%DynatronicsOutperform Votes30948.58% Underperform Votes32751.42% Do insiders and institutionals believe in HSCS or DYNT? 17.2% of Heart Test Laboratories shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 1.8% of Heart Test Laboratories shares are owned by insiders. Comparatively, 8.0% of Dynatronics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better earnings and valuation, HSCS or DYNT? Dynatronics has higher revenue and earnings than Heart Test Laboratories. Heart Test Laboratories is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$14.70K237.88-$6.61M-$7.91-0.48Dynatronics$33.60M0.03-$2.70M-$0.96-0.14 Does the media refer more to HSCS or DYNT? In the previous week, Heart Test Laboratories had 4 more articles in the media than Dynatronics. MarketBeat recorded 4 mentions for Heart Test Laboratories and 0 mentions for Dynatronics. Heart Test Laboratories' average media sentiment score of 0.88 beat Dynatronics' score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media. Company Overall Sentiment Heart Test Laboratories Positive Dynatronics Neutral SummaryHeart Test Laboratories beats Dynatronics on 10 of the 18 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get Dynatronics News Delivered to You Automatically Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYNT vs. The Competition Export to ExcelMetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$961,000.00$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-0.1425.3790.1317.19Price / Sales0.0345.901,116.25117.01Price / CashN/A43.4443.1037.85Price / Book0.117.094.784.78Net Income-$2.70M$13.64M$120.31M$225.60M7 Day Performance-3.64%-2.93%-1.92%-1.23%1 Month Performance1.84%-1.42%13.65%0.46%1 Year Performance-77.34%39.20%28.34%15.24% Dynatronics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYNTDynatronicsN/A$0.13flatN/A-75.9%$961,000.00$33.60M-0.14200Analyst ForecastGap DownHSCSHeart Test Laboratories2.2792 of 5 stars$3.81+1.1%$15.00+293.7%-75.7%$3.48M$18,600.00-0.1710Earnings ReportAnalyst ForecastNews CoverageGap UpQNRXQuoin Pharmaceuticals2.9084 of 5 stars$0.63-4.8%$4.00+534.9%-86.3%$3.18MN/A-0.164News CoverageGap DownBJDXBluejay Diagnostics0.3455 of 5 stars$4.99+7.8%N/A-99.7%$2.76M$250,000.000.009BBLGBone Biologics0.4756 of 5 stars$1.10-1.8%N/A-68.0%$2.71MN/A0.002News CoverageVEROVenus Concept1.6196 of 5 stars$0.34-3.2%N/A-68.0%$2.47M$67.20M-0.04410Gap UpNAOVNanoVibronixN/A$0.64+4.8%N/A-44.7%$2.42M$2.28M-0.5020Gap DownHigh Trading VolumeNDRAENDRA Life Sciences1.4448 of 5 stars$4.24-0.7%$700,000.00+16,509,334.0%-100.0%$2.29MN/A-0.0120Positive NewsGap UpHSDTHelius Medical Technologies2.6361 of 5 stars$0.47-4.0%$24.00+5,001.0%-87.0%$1.75M$502,000.00-0.0830Short Interest ↓Positive NewsGap DownAFIBAcutus MedicalN/A$0.06-10.9%N/A-68.4%$1.70M$7.16M0.00340Gap DownAVGRAvinger2.3465 of 5 stars$0.50-20.7%$5.00+900.0%-81.4%$1.65M$7.26M-0.0570Analyst ForecastNews Coverage Related Companies and Tools Related Companies Heart Test Laboratories Competitors Quoin Pharmaceuticals Competitors Bluejay Diagnostics Competitors Bone Biologics Competitors Venus Concept Competitors NanoVibronix Competitors ENDRA Life Sciences Competitors Helius Medical Technologies Competitors Acutus Medical Competitors Avinger Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DYNT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynatronics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynatronics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
